Binoy Bhansali was previously at Sandbox Industries, which manages $1.2bn across four funds for health insurer Blue Cross Blue Shield.
Month: March 2021
Demand for fashion remains strong
Amy Sun, partner at venture capital firm Sequoia, has a nice line in Atlantic magazine’s latest magazine feature: “The age of conformity is over.”
Rising Stars Q&A – Kurt Sheline, Echo Health Ventures
Q&A with Kurt Sheline, principal, Echo Health Ventures
Fondeadora fattens series A to $28m
Google subsidiary Gradient Ventures returned for a $14m second tranche of the round, having led the August 2020 first close.
VLP Therapeutics raises $16m
Konishiyasu and Sojitz contributed to a series A round for the cancer vaccine developer, which expanded to their home of Japan last year.
Corporates help ElevateBio get $525m lift
SoftBank Vision Fund 2, Itochu and an unnamed insurer took part in a series C round that hiked the gene and cell therapy developer’s total funding to $845m.
Variantyx picks IBM for $20m series C
IBM Ventures participated in a $20m round for the neurological disease diagnostics technology developer, a spinout from Tel Aviv University.
EyeYon Medical spies series C investors
The ophthalmic treatment developer has now raised almost $36m in total, with CR-CP Life Science Fund having led a $25m round.
Cruise takes Voyage in acquisition deal
Autonomous taxi developer Voyage had received a total of $52m from investors including InMotion Ventures and Chevron Technology Ventures.
WndrCo gets seat at Airtable in $270m round
The database software provider more than doubled its valuation to nearly $5.8bn in a series E round that boosted its cash on hand to about $500m.
Insitro intercepts $400m
Softbank Investment Advisors and existing investor GV contributed to a series C round boosting the drug discovery platform developer’s overall funding to over $640m.
CureApp gets funding treatment
Dai-ichi Life, Itochu Technology Ventures, Koshidaka and Toyoshima CVC were among the investors that backed the medical therapy booking platform’s $19.3m round.
Kunlun climbs to $2bn valuation
Legend Capital was among the investors in a round of undisclosed size for Kunlun, an AI chip subsidiary of Baidu, at a valuation of about $2bn.
Alvotech amplifies private placement to $100m
Baxter Healthcare was among the investors in the $65m first close of a private placement the biosimilar drug developer has pushed to $100m.